FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans-Jörg Bühring

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Physiology

Living Beings

Mouse

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Jens Schreiner; Stefan Stevanovic; Ji Ming Wang; Sandra Beer-Hammer; Hans-Jörg Bühring; Juliane Klenk; Dorothee Kretschmer; Michael Otto; Andreas Peschel; Stella Eugenie Autenrieth
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.
Stefan Wirths; Hans-Jörg Bühring; Falko Fend; Claus Hann von Weyhern; Lothar Kanz; Torsten Kluba; Elke Malenke; Frank Mayer; Martin R Müller; Florian Nagl; Simone Rieger; Sabine Schleicher; Wichard Vogel; Hans-Georg Kopp
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.
Tilman Todenhöfer; Arnulf Stenzl; Stefan Aufderklamm; Gunnar Blumenstock; Hans-Jörg Bühring; Tanja Fehm; Georgios Gakis; Sabrina Grimm; Jörg Hennenlotter; Andrea Hohneder; Ursula Kühs; Helmut R Salih; David Schilling; Benjamin Joachim Schmiedel; Christian Schwentner
Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans-Jörg Bühring (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jens Schreiner; Stefan Stevanovic; Ji Ming Wang; Sandra Beer-Hammer; Hans-Jörg Bühring; Juliane Klenk; Dorothee Kretschmer; Michael Otto; Andreas Peschel; Stella Eugenie Autenrieth
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(7):3417-26.
2013: Stefan Wirths; Hans-Jörg Bühring; Falko Fend; Claus Hann von Weyhern; Lothar Kanz; Torsten Kluba; Elke Malenke; Frank Mayer; Martin R Müller; Florian Nagl; Simone Rieger; Sabine Schleicher; Wichard Vogel; Hans-Georg Kopp
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.
Stem cells translational medicine 2013;2(1):53-60.
2013: Tilman Todenhöfer; Arnulf Stenzl; Stefan Aufderklamm; Gunnar Blumenstock; Hans-Jörg Bühring; Tanja Fehm; Georgios Gakis; Sabrina Grimm; Jörg Hennenlotter; Andrea Hohneder; Ursula Kühs; Helmut R Salih; David Schilling; Benjamin Joachim Schmiedel; Christian Schwentner
Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.
The Prostate 2013;73(2):162-8.
2012: Kavitha Sivasubramaniyan; Malgorzata Sobiesiak; Harald Abele; Wilhelm K Aicher; Flavianna Cerabona; Peter de Zwart; Christoph Faul; Roshanak Ghazanfari; Sabrina Grimm; Abhishek Harichandan; Lothar Kanz; Daniela Lehnen; Elisabeth Mortha; Neli Petkova; Hans-Jörg Bühring
Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets.
Annals of the New York Academy of Sciences 2012;1266():94-106.
2012: Elisabeth Höring; Michel Mittelbronn; Shohag Bhattacharyya; Hans-Jörg Bühring; Patrick Nikolaus Harter; Jens Schittenhelm; Janina Jansong; Elke von Hattingen; Cornelia Zachskorn; Ulrike Naumann
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Acta neuropathologica 2012;124(1):83-97.
2012: M Hofmann; Steffen Aulwurm; M L Bamberg; Hans-Jörg Bühring; Ludger Grosse-Hovest; S P Haen; T Nübling; E Pyż; Hans-Georg Rammensee; Helmut R Salih; Karin Schilbach; K Schwartz; Gundram Jung
Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.
Leukemia 2012;26(6):1228-37.
2011: Wilhelm K Aicher; Hans-Jörg Bühring; Melanie Hart; Bernd Rolauffs; Andreas Badke; Gerd Klein
Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls.
Advanced drug delivery reviews 2011;63(4-5):342-51.
2011: Gregor A Pilz; Christine Ulrich; Manuel Ruh; Harald Abele; Richard Schäfer; Torsten Kluba; Hans-Jörg Bühring; Bernd Rolauffs; Wilhelm K Aicher
Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells.
Stem cells and development 2011;20(4):635-46.
2011: Abhishek Harichandan; Hans-Jörg Bühring
Prospective isolation of human MSC.
Best practice & research. Clinical haematology 2011;24(1):25-36.
2010: Harald F Langer; Jürgen W von der Ruhr; Karin Daub; Tanja Schoenberger; Konstantinos Stellos; Andreas E May; Hannah Schnell; Alexandra Gauss; Ramona Hafner; Peter Lang; Michael Schumm; Hans-Jörg Bühring; Karin Klingel; Sabine Conrad; Martin Schaller; Marc van Zandvoort; Gundram Jung; Stefanie Dimmeler; Thomas Skutella; Meinrad Gawaz
Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions.
Journal of molecular medicine (Berlin, Germany) 2010;88(7):687-99.
2010: Malgorzata Sobiesiak; Kavitha Sivasubramaniyan; Clemens Hermann; Charmaine Tan; Melanie Orgel; Sabrina Treml; Flavianna Cerabona; Peter de Zwart; Uwe Ochs; Claudia A Müller; Caroline E Gargett; Hubert Kalbacher; Hans-Jörg Bühring
The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase.
Stem cells and development 2010;19(5):669-77.
2010: Dorothea Alexander; Fabian Schäfer; Marcus Olbrich; Björn Friedrich; Hans-Jörg Bühring; Jürgen Hoffmann; Siegmar Reinert
MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2010;26(6):1073-80.
2010: Stella Eugenie Autenrieth; Tanja-Rebecca Linzer; Clara Hiller; Birgit Keller; Philipp Warnke; Martin Köberle; Erwin Bohn; Tilo Biedermann; Hans-Jörg Bühring; Günter J Hämmerling; Hans-Georg Rammensee; Ingo B Autenrieth
Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.
PLoS pathogens 2010;6(11):e1001212.
2009: Hans-Jörg Bühring; Sabrina Treml; Flavianna Cerabona; Peter de Zwart; Lothar Kanz; Malgorzata Sobiesiak
Phenotypic characterization of distinct human bone marrow-derived MSC subsets.
Annals of the New York Academy of Sciences 2009;1176():124-34.
2009: Venkata Lokesh Battula; Sabrina Treml; Petra Bareiß; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.
Haematologica 2009;94(2):173-84.
2008: Sabine Conrad; Markus Renninger; Jörg Hennenlotter; Tina Wiesner; Lothar Just; Michael Bonin; Wilhelm Aicher; Hans-Jörg Bühring; Ulrich Mattheus; Andreas Mack; Hans-Joachim Wagner; Stephen Minger; Matthias Matzkies; Michael Reppel; Jürgen Hescheler; Karl-Dietrich Sievert; Arnulf Stenzl; Thomas Skutella
Generation of pluripotent stem cells from adult human testis.
Nature 2008;456(7220):344-9.
2008: Sonja Muffler; Hans-Jürgen Stark; Mara Amoros; Berit Falkowska-Hansen; Karsten Boehnke; Hans-Jörg Bühring; Alexander Marmé; Jackie R Bickenbach; Petra Boukamp
A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures.
Stem cells (Dayton, Ohio) 2008;26(10):2506-15.
2008: Venkata Lokesh Battula; Sabrina Treml; Harald Abele; Hans-Jörg Bühring
Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody.
Differentiation; research in biological diversity 2008;76(4):326-36.
2008: Despina Rudolf; Tobias Silberzahn; Steffen Walter; Dominik Maurer; Johanna Engelhard; Dorothee Wernet; Hans-Jörg Bühring; Gundram Jung; Byoung S Kwon; Hans-Georg Rammensee; Stefan Stevanović
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Cancer immunology, immunotherapy : CII 2008;57(2):175-83.
2008: Karoline Sonneck; Christian Baumgartner; Laura Rebuzzi; K Marth; Kuan-Wei Chen; Alexander W Hauswirth; Stefan Florian; Susanne Vrtala; Hans-Jörg Bühring; Rudolf Valenta; Peter Valent
Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.
International journal of immunopathology and pharmacology 2008;21(1):11-21.
2007: Alwin Scharstuhl; Bernhard Schewe; Karin Benz; Christoph Gaissmaier; Hans-Jörg Bühring; reinout stoop
Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology.
Stem cells (Dayton, Ohio) 2007;25(12):3244-51.
2007: Hans-Jörg Bühring; Venkata Lokesh Battula; Sabrina Treml; Bernhard Schewe; Lothar Kanz; Wichard Vogel
Novel markers for the prospective isolation of human MSC.
Annals of the New York Academy of Sciences 2007;1106():262-71.
2007: Venkata Lokesh Battula; Petra Bareiß; Sabrina Treml; Sabine Conrad; Ingrid Albert; Sigrid Hojak; Harald Abele; Bernhard Schewe; Lothar Just; Thomas Skutella; Hans-Jörg Bühring
Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation.
Differentiation; research in biological diversity 2007;75(4):279-91.
2006: Z Zhang; Jens Schittenhelm; K Guo; Hans-Jörg Bühring; Katrin Trautmann; Richard Meyermann; Hermann J Schluesener
Upregulation of frizzled 9 in astrocytomas.
Neuropathology and applied neurobiology 2006;32(6):615-24.
2006: Stefan Florian; Karoline Sonneck; M Czerny; F Hennersdorf; Alexander W Hauswirth; Hans-Jörg Bühring; Peter Valent
Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies.
Allergy 2006;61(9):1054-62.
2005: Steffen Walter; Gilles Bioley; Hans-Jörg Bühring; Sven Koch; Dorothee Wernet; Alfred Zippelius; Graham Pawelec; Pedro Romero; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.
European journal of immunology 2005;35(10):2876-85.
2005: Kerol Bartolović; Stefan Balabanov; Birgit Berner; Hans-Jörg Bühring; Martina Komor; Sven Becker; Dieter Hoelzer; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length.
Stem cells (Dayton, Ohio) 2005;23(7):946-57.
2005: Karin Schilbach; Gunter Kerst; Steffen Walter; Matthias Eyrich; Dorothee Wernet; Rupert Handgretinger; WeiDong Xie; Hans-Georg Rammensee; Ingo Müller; Hans-Jörg Bühring; Dietrich Niethammer
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Blood 2005;106(1):144-9.
2005: Stefan Florian; Minoo Ghannadan; Matthias Mayerhofer; Karl J Aichberger; Alexander W Hauswirth; Gerit-Holger Schernthaner; Dieter Printz; Gerhard Fritsch; Alexandra Böhm; Karoline Sonneck; Maria-Theresa Krauth; Martin R Müller; Christian Sillaber; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Journal of leukocyte biology 2005;77(6):984-92.
2005: Florian Hennersdorf; Stefan Florian; Andreas Jakob; Katharina Baumgärtner; Karoline Sonneck; Alfred Nordheim; Tilo Biedermann; Peter Valent; Hans-Jörg Bühring
Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation.
Cell research 2005;15(5):325-35.
2004: Peter Valent; Michel AROCK; Stephan C Bischoff; Hans-Jörg Bühring; Knut Brockow; Luis Escribano; Manuela Födinger; Jürgen Grabbe; Karin Hartmann; Beate M Henz; Hans-Peter Horny; Hanneke C Kluin-Nelemans; Margarida Lima; Gianni Marone; Alberto Orfao; Reza Parwaresch; Christian Sillaber; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Jasper J van Doormaal; Klaus Wolff; Torsten Zuberbier
The European Competence Network on Mastocytosis (ECNM).
Wiener klinische Wochenschrift 2004;116(19-20):647-51.
2004: Hans-Jörg Bühring; Anna Streble; Peter Valent
The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis.
International archives of allergy and immunology 2004;133(4):317-29.
2004: Peter Valent; Alexander W Hauswirth; Susanne Natter; Wolfgang R Sperr; Hans-Jörg Bühring; Rudolf Valenta
Assays for measuring in vitro basophil activation induced by recombinant allergens.
Methods (San Diego, Calif.) 2004;32(3):265-70.
2004: Kerol Bartolovic; Stefan Balabanov; Ulrike Hartmann; Martina Komor; Andreas M Boehmler; Hans-Jörg Bühring; Robert Möhle; Dieter Hoelzer; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Inhibitory effect of imatinib on normal progenitor cells in vitro.
Blood 2004;103(2):523-9.
2004: Hans-Jörg Bühring; Selim Kuçi; Tim Conze; Gisa Rathke; Kerol Bartolović; Frank Grünebach; Marwa Scherl-Mostageer; Tim H Brümmendorf; Norbert Schweifer; Reiner Lammers
CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Stem cells (Dayton, Ohio) 2004;22(3):334-43.
2003: Manuel A Friese; Michael Platten; Stefan Z Lutz; Ulrike Naumann; Steffen Aulwurm; Felix Bischof; Hans-Jörg Bühring; Johannes Dichgans; Hans-Georg Rammensee; Alexander Steinle; Michael Weller
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Cancer research 2003;63(24):8996-9006.
2003: Nicolas Anfossi; Mathias Lucas; Andreas Diefenbach; Hans-Jörg Bühring; David H Raulet; Elena Tomasello; Eric Vivier
Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
European journal of immunology 2003;33(12):3514-22.
2003: Steffen Walter; Leah Herrgen; Oliver Schoor; Gundram Jung; Dorothee Wernet; Hans-Jörg Bühring; Hans-Georg Rammensee; Stefan Stevanović
Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):4974-8.
2003: Wichard Vogel; Frank Grünebach; Conrad A Messam; Lothar Kanz; Wolfram Brugger; Hans-Jörg Bühring
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells.
Haematologica 2003;88(2):126-33.
2003: Selim Kuçi; Johannes T Wessels; Hans-Jörg Bühring; Karin Schilbach; Michael Schumm; Guido Seitz; Jürgen Löffler; Peter Bader; Paul G Schlegel; Dietrich Niethammer; Rupert Handgretinger
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
Blood 2003;101(3):869-76.
2003: Yasamin Majlesi; Puchit Samorapoompichit; Alexander W Hauswirth; Gerit-Holger Schernthaner; Minoo Ghannadan; Mehrdad Baghestanian; Abdolreza Rezaie-Majd; Rudolf Valenta; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3.
Journal of leukocyte biology 2003;73(1):107-17.
2002: Marc Binder; Gerhard Fierlbeck; Te iaoP King; Peter Valent; Hans-Jörg Bühring
Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
International archives of allergy and immunology 2002;129(2):160-8.
2002: Alexander W Hauswirth; Susanne Natter; Minoo Ghannadan; Yasamin Majlesi; Gerit-Holger Schernthaner; Wolfgang R Sperr; Hans-Jörg Bühring; Rudolf Valenta; Peter Valent
Recombinant allergens promote expression of CD203c on basophils in sensitized individuals.
The Journal of allergy and clinical immunology 2002;110(1):102-9.
2002: Reiner Lammers; Christina Giesert; Frank Grünebach; Anke Marxer; Wichard Vogel; Hans-Jörg Bühring
Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.
Experimental hematology 2002;30(6):537-45.
2002: Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Martin R Müller; Walter Klepetko; Georg Schatzl; Wolfgang R Sperr; Hans-Jörg Bühring; Peter Valent
Detection of novel CD antigens on the surface of human mast cells and basophils.
International archives of allergy and immunology 2002;127(4):299-307.
2001: I J Platz; M Binder; Anke Marxer; G Lischka; Peter Valent; Hans-Jörg Bühring
Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
International archives of allergy and immunology 2001;126(4):335-42.
2001: Wolfgang Füreder; Gerit-Holger Schernthaner; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Hans Semper; Yasamin Majlesi; Jörg Zwirner; Otto Götze; Hans-Jörg Bühring; Klaus Lechner; Peter Valent
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes.
European journal of clinical investigation 2001;31(10):894-901.
2001: Peter Brossart; A Schneider; P Dill; T Schammann; Frank Grünebach; Stefan Wirths; Lothar Kanz; Hans-Jörg Bühring; Wolfram Brugger
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
Cancer research 2001;61(18):6846-50.
2001: Wolfram Brugger; A Schneider; T Schammann; P Dill; Frank Grünebach; Hans-Jörg Bühring; Lothar Kanz; Peter Brossart
Dendritic cell-based vaccines in patients with hematological malignancies.
Annals of the New York Academy of Sciences 2001;938():359-62; discussion 362-3.
2001: Christina Giesert; Graça Almeida-Porada; A Scheffold; Lothar Kanz; Esmail D Zanjani; Hans-Jörg Bühring
The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells.
Annals of the New York Academy of Sciences 2001;938():175-83.
2001: Hans-Jörg Bühring; M Seiffert; Christina Giesert; Anke Marxer; Lothar Kanz; Peter Valent; K Sano
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3.
Blood 2001;97(10):3303-5.
2001: John-Hendrik Jordan; S Walchshofer; Wolfgang Jurecka; Isabella Mosberger; Wolfgang R Sperr; Klaus Wolff; Andreas Chott; Hans-Jörg Bühring; Klaus Lechner; Hans-Peter Horny; Peter Valent
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Human pathology 2001;32(5):545-52.
2001: M Seiffert; Peter Brossart; C Cant; M Cella; Marco COLONna; Wolfram Brugger; Lothar Kanz; A Ullrich; Hans-Jörg Bühring
Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells.
Blood 2001;97(9):2741-9.
2001: Arnaud Moris; Volker Teichgräber; L Gauthier; Hans-Jörg Bühring; Hans-Georg Rammensee
Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):4818-21.
2001: Peter Valent; Gerit-Holger Schernthaner; Wolfgang R Sperr; Gerhard Fritsch; Hermine Agis; Martin Willheim; Hans-Jörg Bühring; A Orfao; Luis Escribano
Variable expression of activation-linked surface antigens on human mast cells in health and disease.
Immunological reviews 2001;179():74-81.
2000: Elena Tomasello; C Cant; Hans-Jörg Bühring; Frédéric Vély; Pascale André; M Seiffert; A Ullrich; Eric Vivier
Association of signal-regulatory proteins beta with KARAP/DAP-12.
European journal of immunology 2000;30(8):2147-56.
2000: R Doyonnas; J Yi-Hsin Chan; LH Butler; I Rappold; Jane Lee-Prudhoe; Andrew C W Zannettino; Paul J Simmons; Hans-Jörg Bühring; Jean-Pierre Levesque; Suzanne M Watt
CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(2):840-51.
2000: Suzanne M Watt; LH Butler; Manuela Tavian; Hans-Jörg Bühring; I Rappold; Paul J Simmons; Andrew C W Zannettino; D Buck; A Fuchs; R Doyonnas; J Y-H Chan; Jean-Pierre Levesque; Bruno Peault; Ioannis Roxanis
Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.
Blood 2000;95(10):3113-24.
2000: Stefan Scheding; Bernhard Meister; Hans-Jörg Bühring; C M Baum; J P Mc Kearn; TA Bock; Lothar Kanz; Wolfram Brugger
Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
Experimental hematology 2000;28(4):460-70.
2000: K Kratz-Albers; Stefan Scheding; Robert Möhle; Hans-Jörg Bühring; C M Baum; J P Mc Kearn; T Büchner; Lothar Kanz; Wolfram Brugger
Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.
Experimental hematology 2000;28(3):335-46.
2000: Wolfram Brugger; Stefan Scheding; BL Ziegler; Hans-Jörg Bühring; Lothar Kanz
Ex vivo manipulation of hematopoietic stem and progenitor cells.
Seminars in hematology 2000;37(1 Suppl 2):42-9.
2000: J Dietrich; M Cella; M Seiffert; Hans-Jörg Bühring; Marco COLONna
Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(1):9-12.
1999: M Seiffert; C Cant; Z Chen; I Rappold; Wolfram Brugger; Lothar Kanz; E J Brown; A Ullrich; Hans-Jörg Bühring
Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.
Blood 1999;94(11):3633-43.
1999: Hans-Jörg Bühring; Paul J Simmons; M Pudney; Robert Müller; D Jarrossay; A van Agthoven; M Willheim; Wolfram Brugger; Peter Valent; Lothar Kanz
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.
Blood 1999;94(7):2343-56.
1999: Hans-Jörg Bühring; M Seiffert; Anke Marxer; B Weiss; C Faul; Lothar Kanz; Wolfram Brugger
AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors.
Blood 1999;94(2):832-3.
1999: BL Ziegler; Robert Müller; Mauro Valtieri; C P Lamping; CA Thomas; Marco Gabbianelli; Christina Giesert; Hans-Jörg Bühring; Lothar Kanz; Cesare Peschle
Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level.
Blood 1999;93(10):3355-68.
1999: Wolfram Brugger; Hans-Jörg Bühring; Frank Grünebach; Wichard Vogel; S Kaul; R Müller; Tim H Brümmendorf; BL Ziegler; I Rappold; Peter Brossart; Stefan Scheding; Lothar Kanz
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1535-44.
1999: Wolfram Brugger; Peter Brossart; Stefan Scheding; Gernot Stuhler; K Heinrich; Volker L Reichardt; Frank Grünebach; Hans-Jörg Bühring; Lothar Kanz
Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation.
Annals of the New York Academy of Sciences 1999;872():363-71.
1999: TA Bock; BL Ziegler; Hans-Jörg Bühring; Stefan Scheding; Wolfram Brugger; Lothar Kanz
Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.
Annals of the New York Academy of Sciences 1999;872():200-7; discussion 207-10.
1999: Hans-Jörg Bühring; M Seiffert; TA Bock; Stefan Scheding; A Thiel; A Scheffold; Lothar Kanz; Wolfram Brugger
Expression of novel surface antigens on early hematopoietic cells.
Annals of the New York Academy of Sciences 1999;872():25-38; discussion 38-9.
1999: Michael Schumm; Peter Lang; G Taylor; Selim Kuçi; Thomas Klingebiel; Hans-Jörg Bühring; A Geiselhart; Dietrich Niethammer; Rupert Handgretinger
Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device.
Journal of hematotherapy 1999;8(2):209-18.
1998: Andrew C W Zannettino; Hans-Jörg Bühring; Silvana Niutta; Suzanne M Watt; M A Benton; Paul J Simmons
The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.
Blood 1998;92(8):2613-28.
1998: Suzanne M Watt; Hans-Jörg Bühring; I Rappold; J Y-H Chan; Jane Lee-Prudhoe; T Jones; Andrew C W Zannettino; Paul J Simmons; R Doyonnas; Denise Sheer; LH Butler
CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.
Blood 1998;92(3):849-66.
1998: W Hagen; Josef D Schwarzmeier; S Walchshofer; Niklas Zojer; Andreas Chott; Christian Sillaber; Jutta Ackermann; Ingrid Simonitsch; Hans-Jörg Bühring; Johannes Drach; Klaus Lechner; Hans-Peter Horny; Peter Valent
A case of bone marrow mastocytosis associated with multiple myeloma.
Annals of hematology 1998;76(3-4):167-74.
1997: I Rappold; BL Ziegler; I Köhler; Sylvie Marchetto; O Rosnet; Daniel Birnbaum; Paul J Simmons; Andrew C W Zannettino; B Hill; S Neu; W Knapp; Riitta Alitalo; Kari Alitalo; A Ullrich; Lothar Kanz; Hans-Jörg Bühring
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
Blood 1997;90(1):111-25.
1996: Wolfram Brugger; Stefan Scheding; W Vogel; TA Bock; Hans-Jörg Bühring; BL Ziegler; Lothar Kanz
Ex vivo manipulations of CD34+ peripheral blood progenitor cells.
Bone marrow transplantation 1996;18 Suppl 1():S5-7.
1996: BL Ziegler; S Thoma; C P Lamping; Mauro Valtieri; Robert Müller; Paola Samoggia; Hans-Jörg Bühring; Cesare Peschle; Theodor M Fliedner
Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells.
Cytometry 1996;25(1):46-57.
1996: P Batard; P Sansilvestri; C Scheinecker; W Knapp; N Debili; W Vainchenker; Hans-Jörg Bühring; Marie-Noëlle Monier; E Kukk; J Partanen; M T Matikainen; Riitta Alitalo; Jacques A Hatzfeld; Kari Alitalo
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.
Blood 1996;87(6):2212-20.
1996: O Rosnet; Hans-Jörg Bühring; Sylvie Marchetto; I Rappold; C Lavagna; Danielle Sainty; Christine Arnoulet; Christian Chabannon; Lothar Kanz; C Hannum; Daniel Birnbaum
Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Leukemia 1996;10(2):238-48.
1996: O Rosnet; Hans-Jörg Bühring; O deLapeyrière; Nathalie Beslu; C Lavagna; Sylvie Marchetto; I Rappold; H G Drexler; Françoise Birg; R Rottapel; C Hannum; Patrice Dubreuil; Daniel Birnbaum
Expression and signal transduction of the FLT3 tyrosine kinase receptor.
Acta haematologica 1996;95(3-4):218-23.
1996: Hans-Jörg Bühring; T Müller; Ronald Herbst; S Cole; I Rappold; W Schuller; X Zhu; U Fritzsch; C Faul; S Armeanu; A Ullrich; G Klein; H Schmidt
The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.
Leukemia 1996;10(1):106-16.
1995: S Armeanu; Hans-Jörg Bühring; Monika A Reuss-Borst; C A Müller; G Klein
E-cadherin is functionally involved in the maturation of the erythroid lineage.
The Journal of cell biology 1995;131(1):243-9.
1995: Hans-Jörg Bühring; Irmi Sures; Bahija Jallal; F U Weiss; F W Busch; Wolf-Dieter Ludwig; Rupert Handgretinger; H D Waller; A Ullrich
The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
Blood 1995;86(5):1916-23.
1994: M Adibzadeh; Hans-Jörg Bühring; Thomas Daikeler; P Siegels-Hübenthal; M Owsianowsky; A Schenk; A Rehbein; K Schaudt; E Schlotz; H Pohla
Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro.
Cellular immunology 1994;154(1):25-42.
1994: Monika A Reuss-Borst; Hans-Jörg Bühring; H Schmidt; C A Müller
AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Leukemia 1994;8(2):258-63.
1993: Hans-Jörg Bühring; Ronald Herbst; G Kostka; B Bossenmaier; I Bartke; Harald Kropshofer; Hubert Kalbacher; F W Busch; Claudia A Müller; J Schlessinger
Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
Cancer research 1993;53(18):4424-31.
1993: Rupert Handgretinger; H J Schäfer; F Baur; D Frank; C Ottenlinger; Hans-Jörg Bühring; Dietrich Niethammer
Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells.
Immunology letters 1993;37(2-3):223-8.
1993: H Pohla; M Adibzadeh; Hans-Jörg Bühring; P Siegels-Hübenthal; T Deikeler; M Owsianowsky; A Schenk; A Rehbein; E Schlotz; K Schaudt
Evolution of a CD3+CD4+ alpha/beta T-cell receptor+ mature T-cell clone from CD3-CD7+ sorted human bone marrow cells.
Developmental immunology 1993;3(3):197-210.
1992: Monika A Reuss-Borst; Hans-Jörg Bühring; G Klein; C A Müller
Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.
Annals of hematology 1992;65(4):169-74.
1992: Monika A Reuss-Borst; B Steinke; H D Waller; Hans-Jörg Bühring; C A Müller
Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia.
Annals of hematology 1992;64(2):78-82.
1992: A Gougos; S St Jacques; A Greaves; P J O'Connell; A J d'Apice; Hans-Jörg Bühring; Carmelo Bernabeu; J A van Mourik; Michelle Letarte
Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts.
International immunology 1992;4(1):83-92.
1991: Hans-Jörg Bühring; Claudia A Müller; Michelle Letarte; A Gougos; A Saalmüller; A J van Agthoven; F W Busch
Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.
Leukemia 1991;5(10):841-7.
1991: Hans-Jörg Bühring; A Ullrich; K Schaudt; Claudia A Müller; F W Busch
The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
Leukemia 1991;5(10):854-60.
1991: Graham Pawelec; Hans-Jörg Bühring
Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with gamma/delta rather than alpha/beta antigen receptors.
Human immunology 1991;31(3):165-9.
1991: Hans-Jörg Bühring; A Saalmüller; C Müller; A J van Agthoven; F W Busch
The monoclonal antibody 11G7 recognizes a novel differentiation antigen expressed on hemopoietic precursor cells.
Hybridoma 1991;10(1):77-88.
1991: Graham Pawelec; H J Lenz; E Schneider; Hans-Jörg Bühring; A Rehbein; P Baumgärtner; Gerhard Ehninger
Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status.
Biotherapy (Dordrecht, Netherlands) 1991;3(4):309-18.
1990: Graham Pawelec; K Schaudt; A Rehbein; D Olive; Hans-Jörg Bühring
Human T cell clones with gamma/delta and alpha/beta receptors are differently stimulated by monoclonal antibodies to CD2.
Cellular immunology 1990;129(2):385-93.
1990: Graham Pawelec; Hans-Jörg Bühring
Expression of MHC class II epitopes on human T lymphocyte clones.
Cellular immunology 1990;127(2):520-6.
1990: Graham Pawelec; Hans-Jörg Bühring; C Müller
Involvement of CD45 in MHC class II-allospecific cytotoxicity.
Cellular immunology 1990;127(2):514-9.
1990: Graham Pawelec; U Schwuléra; H Lenz; M Owsianowski; Hans-Jörg Bühring; H Schlag; E Schneider; K Schaudt; Gerhard Ehninger
Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2.
Molecular biotherapy 1990;2(1):44-9.
1990: Graham Pawelec; Gerhard Ehninger; H Schmidt; C Müller; Hans-Jörg Bühring; M Reutter; F W Busch
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.
Cancer immunology, immunotherapy : CII 1990;32(3):167-72.